3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Mucositis
1
Esophagitis
1
Breast Neoplasms
1
Interventions
Surgical Procedures, Operative
2
Music Therapy
2
Letrozole
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
sacituzumab govitecan
1
ribociclib
1
pembrolizumab
1
exemestane
1
dalpiciclib
1
Zoledronic Acid
1
Vitamin D
1
Transurethral Resection of Bladder
1
Therapeutics
1
Tamoxifen
1
Synbiotics
1
Self-Help Groups
1
Resistance Training
1
Relaxation Therapy
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Prebiotics
1
Oxygen Inhalation Therapy
1
Neoadjuvant Therapy
1
Mastectomy, Segmental
1
Mastectomy, Modified Radical
1
Mastectomy
1
Mannitol
1
Mammography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Alginates
×
Breast
×
Clear all
NCT06958445
2025-05-06
SAFE
Taipei City Hospital
Phase 2
Enrolling by invitation
90 enrolled